Pharmakotherapie von Schlaf-Wach-Störungen

Keyphrases

• Pharmacotherapy 100%
• Receptor Antagonist 100%
• Mild Cases 100%
• Sleep-wake Disorders 100%
• Brain Regions 50%
• Drug Use 50%
• Pharmacological Treatment 50%
• Tricyclic Antidepressants 50%
• Cognitive Behavioral Therapy 50%
• Caffeine 50%
• Treatment Options 50%
• Excessive Daytime Sleepiness 50%
• Continuous Positive Airway Pressure 50%
• Sleep Apnea 50%
• Alertness 50%
• Wakefulness 50%
• 5-HT Receptors 50%
• Neurochemicals 50%
• Melatonin 50%
• Complex Behavior 50%
• Orexin 50%
• Exogenous Melatonin 50%
• Insomnia 50%
• Modafinil 50%
• 5-HT2C Receptor 50%
• Histamine H1 Receptor Antagonist 50%
• Brain Neurotransmitters 50%
• Amphetamine Derivatives 50%
• Sleep-promoting 50%
• Non-benzodiazepine 50%
• Z-hypnotics 50%
• Melatonin Receptor Agonists 50%
• Drug Binding 50%
• Hypocretin Receptor 50%
• GABAergic Drugs 50%
• Pharmacological Combination 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacotherapy 100%
• Sleep Disorder 100%
• Melatonin 100%
• 4 Aminobutyric Acid 50%
• Benzodiazepine 50%
• Tricyclic Antidepressant 50%
• Neurotransmitter 50%
• Sleep Disordered Breathing 50%
• Dopamine Receptor Stimulating Agent 50%
• Hypnotic 50%
• Daytime Somnolence 50%
• Orexin 50%
• Histamine H1 Receptor Antagonist 50%
• Amphetamine Derivative 50%
• Modafinil 50%
• Serotonin 2C Antagonist 50%
• Orexin Receptor Antagonist 50%
• Melatonin Receptor Agonist 50%